Furthermore, Luteolin caused a decrement in the xenograft tumor VEGF expression and blood-vessel density and inhibited the medroxyprogesterone acetate-induced acquisition of stem cell-like properties by breast cancer cells. The gene discussed is VEGFA; the disease is breast cancer.